166 related articles for article (PubMed ID: 38390332)
1. Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8
Luo J; Shi X; Liu Y; Wang J; Wang H; Yang X; Sun Q; Hui Z; Wei F; Ren X; Zhao H
Front Immunol; 2024; 15():1302761. PubMed ID: 38390332
[TBL] [Abstract][Full Text] [Related]
2. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
[TBL] [Abstract][Full Text] [Related]
3. High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC.
Ye D; Jin Y; Weng Y; Cui X; Wang J; Peng M; Song Q
Sci Rep; 2023 Sep; 13(1):16468. PubMed ID: 37777573
[TBL] [Abstract][Full Text] [Related]
4. High endothelial venules (HEVs) in immunity, inflammation and cancer.
Blanchard L; Girard JP
Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.
Asrir A; Tardiveau C; Coudert J; Laffont R; Blanchard L; Bellard E; Veerman K; Bettini S; Lafouresse F; Vina E; Tarroux D; Roy S; Girault I; Molinaro I; Martins F; Scoazec JY; Ortega N; Robert C; Girard JP
Cancer Cell; 2022 Mar; 40(3):318-334.e9. PubMed ID: 35120598
[TBL] [Abstract][Full Text] [Related]
6. High endothelial venules in cancer: Regulation, function, and therapeutic implication.
Vella G; Hua Y; Bergers G
Cancer Cell; 2023 Mar; 41(3):527-545. PubMed ID: 36827979
[TBL] [Abstract][Full Text] [Related]
7. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.
Martinet L; Garrido I; Filleron T; Le Guellec S; Bellard E; Fournie JJ; Rochaix P; Girard JP
Cancer Res; 2011 Sep; 71(17):5678-87. PubMed ID: 21846823
[TBL] [Abstract][Full Text] [Related]
8. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1
Hua Y; Vella G; Rambow F; Allen E; Antoranz Martinez A; Duhamel M; Takeda A; Jalkanen S; Junius S; Smeets A; Nittner D; Dimmeler S; Hehlgans T; Liston A; Bosisio FM; Floris G; Laoui D; Hollmén M; Lambrechts D; Merchiers P; Marine JC; Schlenner S; Bergers G
Cancer Cell; 2022 Dec; 40(12):1600-1618.e10. PubMed ID: 36423635
[TBL] [Abstract][Full Text] [Related]
10. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
Martinet L; Le Guellec S; Filleron T; Lamant L; Meyer N; Rochaix P; Garrido I; Girard JP
Oncoimmunology; 2012 Sep; 1(6):829-839. PubMed ID: 23162750
[TBL] [Abstract][Full Text] [Related]
11. Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.
Sawada J; Hiraoka N; Qi R; Jiang L; Fournier-Goss AE; Yoshida M; Kawashima H; Komatsu M
Cancer Immunol Res; 2022 Apr; 10(4):468-481. PubMed ID: 35201289
[TBL] [Abstract][Full Text] [Related]
12. The relationship of the tertiary lymphoid structures with the tumor-infiltrating lymphocytes and its prognostic value in gastric cancer.
Zhang N; Zhang G; Wang D; Liu H; Zhang Y; Ayarick VA; Han X; Lv Y; Wang Y
Arch Med Sci; 2024; 20(1):255-266. PubMed ID: 38414448
[TBL] [Abstract][Full Text] [Related]
13. 4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment.
Sellæg K; Schwienbacher R; Kranz M; Aamodt AE; Wirsing AM; Berge G; Hadler-Olsen E; Magnussen SN
Front Oncol; 2024; 14():1343839. PubMed ID: 38812785
[TBL] [Abstract][Full Text] [Related]
14. Correlation with lymphocyte infiltration, but lack of prognostic significance of MECA-79-positive high endothelial venules in primary malignant melanoma.
Sebestyén T; Mohos A; Liszkay G; Somlai B; Gaudi I; Ladányi A
Melanoma Res; 2018 Aug; 28(4):304-310. PubMed ID: 29683859
[TBL] [Abstract][Full Text] [Related]
15. High HPK1
Zhang J; Ren Z; Hu Y; Shang S; Wang R; Ma J; Zhang Z; Wu M; Wang F; Yu J; Chen D
Int Immunopharmacol; 2024 Jan; 127():111363. PubMed ID: 38101218
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analyses of a CD8
Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
18. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028
[TBL] [Abstract][Full Text] [Related]
19. High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer.
Hong SA; Hwang HW; Kim MK; Lee TJ; Yim K; Won HS; Sun S; Kim EY; Ko YH
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823631
[TBL] [Abstract][Full Text] [Related]
20. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
